ADMA in the 13F filings
Adma Biologics Inc · CUSIP 000899104
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 29
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 6 listed it in both
- Shares listed
- 41,676,823
- combined, among listed positions
- Reported value
- $378m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 22 buyers (opened or added shares) and 9 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -3,568,810.
Managers listing ADMA in Q1 2026
29 of 29 holders
Largest increases and reductions, by shares
Increases
- Capital Research Global Investorsexisting position · 11,191,116 shares now+4,553,644
- Citadel Advisors LLCexisting position · 5,810,642 shares now+4,288,072
- Point72 Asset Management LPexisting position · 3,288,757 shares now+2,894,878
- Millennium Management LLCexisting position · 3,434,449 shares now+2,764,778
- Jane Street Group LLCexisting position · 3,051,943 shares now+2,592,519
Reductions
- Invesco Ltdexisting position · 4,119,577 shares now-7,665,625
- Janus Henderson Group Ltdexisting position · 98,261 shares now-3,838,158
- Voloridge Investment Management LLCexisting position · 296,463 shares now-726,787
- Neuberger Berman Group LLCexisting position · 12,937 shares now-368,848
- Renaissance Technologies LLCexisting position · 1,262,634 shares now-269,987
New positions and exits
New (5)
Exited (2)
- Sachem Head Capital Management LPwas $207m
- Holocene Advisors LPwas $11m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2019 | 1 | $8.4m | n.a. | n.a. |
| Q3 2019 | 1 | $7.0m | n.a. | n.a. |
| Q4 2019 | 1 | $5.0m | n.a. | n.a. |
| Q1 2020 | 1 | $2.1m | n.a. | n.a. |
| Q2 2020 | 2 | $2.4m | n.a. | n.a. |
| Q3 2020 | 2 | $6.2m | n.a. | n.a. |
| Q1 2022 | 1 | $4.2m | n.a. | n.a. |
| Q2 2022 | 1 | $4.3m | n.a. | n.a. |
| Q3 2022 | 1 | $4.9m | n.a. | n.a. |
| Q4 2022 | 2 | $7.4m | n.a. | n.a. |
| Q1 2023 | 1 | $678k | n.a. | n.a. |
| Q2 2023 | 2 | $11m | n.a. | n.a. |
| Q3 2023 | 1 | $11m | n.a. | n.a. |
| Q4 2023 | 2 | $13m | 1 | 1 |
| Q1 2024 | 4 | $62m | 4 | 0 |
| Q2 2024 | 6 | $225m | 5 | 1 |
| Q3 2024 | 8 | $378m | 4 | 4 |
| Q4 2024 | 7 | $209m | 3 | 3 |
| Q1 2025 | 7 | $187m | 3 | 4 |
| Q2 2025 | 6 | $88m | 3 | 2 |
| Q3 2025 | 4 | $221m | 2 | 3 |
| Q4 2025 | 8 | $464m | 16 | 17 |
| Q1 2026 | 3 | $106m | 22 | 9 |
| Q2 2026 | 1 | $73m | 10 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ADMA and GILD →ADMA and AMGN →ADMA and ARGX →Choose a stock to compare with ADMA →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ADMA, latest filings →Back to the 13F Explorer →